跳至主要内容
临床试验/NCT01906229
NCT01906229终止不适用

Acute Pulmonary and Systemic Inflammation in Mechanically Ventilated Intensive Care Patients

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
8
试验地点
1
主要终点
Tumor necrosis factor alpha (TNF-a) bioactivity

研究概览

简要总结

Acute respiratory distress syndrome (ARDS) is a devastating form of acute lung inflammation, that may be caused by a variety of insults with pulmonary and systemic infectious disease being the most common predisposing factor. Sepsis, on the other hand, represents the systemic inflammatory response to an invading pathogen, which may inflict damage upon the host through organ dysfunction. ARDS and sepsis are heterogenous clinical conditions that have a high mortality, and both diseases involve a complex interplay of different inflammatory mediators and cell types. It has been suggested that locally released inflammatory mediators pass from the lungs into the bloodstream following ARDS, triggering systemic inflammation. Conversely, it is possible that severe systemic inflammation may lead to ARDS by an influx of inflammatory mediators from the bloodstream to the lungs. However, the time course and the possible pathways for this transmission of disease have yet to be established.

Investigators hypothesize that:

  1. Primary systemic inflammation is followed by a secondary pulmonary inflammatory response
  2. Primary pulmonary inflammation is followed by a secondary systemic inflammatory response
  3. Both primary and secondary inflammatory responses are characterized by the appearance of pro-inflammatory cytokines, inflammatory cells and production of collagen-like proteins (termed 'lectins')
  4. The inflammatory response is most pronounced in the primary afflicted compartment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years
  • Mechanically ventilated
  • < 48 hours after admission to the Intensive Care Unit
  • ARDS: acute (< 1 week) respiratory failure, characterized by hypoxemia (PaO2/FiO2 < 300 mmHg/40kPa), and bilateral infiltrates on x-ray or CT of thorax, that can not be explained by heart failure og overhydration.
  • SIRS (two of the following): Temperature > 38°C or < 36°C, heart rate > 90/min, respiratory frequency > 20 or PaCO2 < 4.2 kPa, leukocytosis (> 12x10^9/L) or leukopenia (< 4x10^9/L)
  • ARDS + SIRS

排除标准

  • One lung ventilation; Tube size < 8.0 mm; INR > 1.5 or thrombocytes < 40x10^9/L; Intracranial hypertension; Malignant arrythmias

结局指标

主要结局

Tumor necrosis factor alpha (TNF-a) bioactivity

时间窗: Day fourteen

次要结局

  • Ficolin-1,2,3(Day one)
  • Interleukin (IL)-6(Day one)
  • Mannose binding lectin (MBL)(Day one)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ronni R. Plovsing

MD

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验